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Caspase-14 Is Required for Filaggrin Degradation
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Esther Hoste1,2,11, Patrick Kemperman3,4,11, Michael Devos1,2,11, Geertrui Denecker1,2, Sanja Kezic5,
Nico Yau5, Barbara Gilbert1,2, Saskia Lippens1,2, Philippe De Groote1,2, Ria Roelandt1,2, Petra Van Damme6,
Kris Gevaert6, Richard B. Presland7,8, Hidenari Takahara9, Gerwin Puppels3,10, Peter Caspers3,10,
Peter Vandenabeele1,2 and Wim Declercq1,2
Caspase-14 is a protease that is mainly expressed in suprabasal epidermal layers and activated during
keratinocyte cornification. Caspase-14-deficient mice display reduced epidermal barrier function and increased
sensitivity to UVB radiation. In these mice, profilaggrin, a protein with a pivotal role in skin barrier function, is
processed correctly to its functional filaggrin (FLG) repeat unit, but proteolytic FLG fragments accumulate in the
epidermis. In wild-type stratum corneum, FLG is degraded into free amino acids, some of which contribute to
generation of the natural moisturizing factors (NMFs) that maintain epidermal hydration. We found that
caspase-14 cleaves the FLG repeat unit and identified two caspase-14 cleavage sites. These results indicate that
accumulation of FLG fragments in caspase-14/ mice is due to a defect in the terminal FLG degradation
pathway. Consequently, we show that the defective FLG degradation in caspase-14-deficient skin results in
substantial reduction in the amount of NMFs, such as urocanic acid and pyrrolidone carboxylic acid. Taken
together, we identified caspase-14 as a crucial protease in FLG catabolism.
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INTRODUCTION
Keratinocytes, the main cell type in the epidermis, undergo a
well-orchestrated differentiation program that leads to the
formation of a functional skin barrier maintained by several
components residing mainly in the stratum corneum (SC;
Proksch et al., 2008; Schauber and Gallo, 2009). In addition,
tight junctions in the stratum granulosum are also key players
in maintaining the water balance in skin (reviewed in Morita
et al., 2011). The SC is the outermost epidermal layer and
consists of corneocytes enshrouded by a cornified envelope
embedded in a specialized lipid bilayer (Elias, 2008). This
heterogeneous ‘‘brick and mortar’’ constitution of the outer
epidermal layers provides a strong protective barrier. Water
retention by the skin is governed by lipids as well as by the
cornified envelope (Imokawa et al., 1989). Cornified envel-
opes, which replace the plasma membrane in corneocytes,
are insoluble protein structures that are tightly crosslinked by
transglutaminases (Candi et al., 2005). The so-called natural
moisturizing factors (NMFs) are a mixture of hygroscopic
molecules including amino acids and their derivatives, e.g.,
pyrrolidone carboxylic acid (PCA) and urocanic acid (UCA),
together with lactic acid, urea, citrate, and sugars (Rawlings
and Harding, 2004). These NMFs absorb water and maintain
hydration in skin of terrestrial animals. In addition, the ionic
interaction between NMF and keratins reduces the inter-
molecular binding between keratin filaments and thereby
increases the elastic properties of the SC (Jokura et al., 1995).
PCA and UCA are derived mainly from complete degradation
of filaggrin (FLG, filament aggregating protein) in the top
layers of the SC (Scott et al., 1982; Scott and Harding, 1986;
Kezic et al., 2008, 2009).
Filaggrin is thought to contribute to epidermal barrier
function by promoting keratin filament aggregation into
macrofibrils in the stratum granulosum and SC layers (Dale
et al., 1985; Sybert et al., 1985). Loss-of-function mutations in
the filaggrin gene (FLG) lead to the development of the dry
skin disease, ichthyosis vulgaris in humans and to a similar
neonatal skin disease in mice (Palmer et al., 2006; Smith
et al., 2006; Fallon et al., 2009). In addition, FLG gene
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mutations predispose individuals to atopic dermatitis (ecze-
ma), which is often associated with other allergies, including
asthma (Palmer et al., 2006; Schuttelaar et al., 2009).
Profilaggrin is synthesized as a large polyprotein precursor
of 4400 kDa consisting of multiple FLG units flanked by
distinct N- and C-terminal domains. The N-terminal domain
contains a conserved S100 calcium-binding domain and a
postulated B-domain. Profilaggrin comprises 10–12 FLG
repeat units in humans and 12–20 in mice, depending on
the strain (Rothnagel and Steinert, 1990; Zhang et al., 2002;
Fallon et al., 2009; Sandilands et al., 2009). In the stratum
granulosum, profilaggrin is highly phosphorylated and
retained in the keratohyalin granules. Profilaggrin is dephos-
phorylated in the transitional layer between stratum granu-
losum and SC before proteolytic cleavage into FLG units
(reviewed in Ovaere et al., 2009; Sandilands et al., 2009).
Once FLG is released, it forms an aggregate with the keratin
intermediate filaments (Dale et al., 1985). FLG is deiminated
in the cornified layers by peptidylarginine deiminase (Nachat
et al., 2005), converting positively charged arginine residues
into citrulline. Subsequently, the FLG–keratin interaction is
broken and FLG is degraded further into free amino acids that
contribute to the NMF (reviewed in Rawlings and Harding,
2004). Consequently, patients carrying loss-of-function FLG
mutations exhibit greatly reduced NMF levels (Kezic et al.,
2008, 2011; O’Regan et al., 2010).
Although several proteases are involved in processing
profilaggrin into FLG, little is known about the proteolytic
events involved in the degradation of FLG into amino acids.
We recently generated caspase-14/ mice and showed that
caspase-14 deficiency leads to the accumulation of fragments
derived from FLG repeats (Denecker et al., 2007), suggesting
that FLG degradation is defective in these mice. Calpain I and
caspase-14 can cleave deiminated FLG repeats in vitro
(Kamata et al., 2009), but the identity of the cleavage
fragments was not reported. We compare FLG processing in
wild-type and caspase-14/ mice and show that FLG
degradation is initiated in caspase-14-deficient mice but
does not complete, resulting in the accumulation of FLG
fragments. Consequently, we demonstrate lower NMF levels
in caspase-14/ mice relative to control mice. We also
identified two caspase-14 cleavage sites in the FLG repeat
unit. Taken together, our results indicate an important role for
caspase-14 in FLG catabolism.
RESULTS
Filaggrin degradation is defective in caspase-14-deficient skin
As reported earlier, the proteolytic generation of the FLG
repeat, which has an apparent molecular weight ofB30 kDa
(Presland et al., 2000), was not affected in caspase-14/
skin, but FLG degradation products accumulated in the
epidermis (Denecker et al., 2007, 2008). We show here that
this accumulation is evident in adults but is even more
pronounced in neonates (Figure 1a). Furthermore, minor FLG
degradation products were also observed in caspase-14þ /þ
epidermis as detected by western blotting using an antibody
directed against the FLG repeat. To validate the nature of
these FLG fragments that accumulate in the absence of
caspase-14, caspase-14þ /þ and caspase-14/ skin lysates
were separated by gel electrophoresis and stained with
Coomassie Blue (Figure 1b). The gel region in which FLG-
derived fragments accumulated most prominently was sub-
jected to protein elution and analyzed by mass spectrometry.
All peptides but one that maps to the N-terminal B-domain of
profilaggrin, map to the FLG repeat sequence (Figure 1c,
Supplementary Figure S1 online). The number of spectra
identified as FLG peptides was 6-fold higher in caspase-14
knockout skin than in wild-type skin, while the number of
spectra derived from the subunits of the actin-related protein
2/3 complex was 5% in both samples (data not shown).
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Figure 1. Aberrant filaggrin processing in caspase-14/ mice. (a) Filaggrin (FLG) immunoblotting of epidermal lysates from caspase-14þ /þ and
caspase-14/ skin shows accumulation of FLG-derived peptides in caspase-14-deficient skin. Anti-actin blot is shown as control for equal loading.
(b) Coomassie blue staining of P5.5 caspase-14þ /þ and caspase-14/ skin lysates. The region in which FLG fragments accumulated in caspase-14/ skin
was clearly visible on the Coomassie-stained gel and was cut out, as well as from the equivalent region of the caspase-14þ /þ gel (indicated with a bar).
Gel slices were analyzed by IonTrap ESI-MS/MS. (c) Table of identified FLG peptides, indicating sequence location within the mouse profilaggrin protein
sequence (IPI00473837.2), and number of spectra by which the observed peptide was represented. Mw, molecular weight markers.
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This confirms that proteolytic fragments of the FLG repeat
accumulate in caspase-14-deficient skin.
It has been shown that degradation of FLG into NMF is
blocked during the late fetal development, and that shortly
after birth normal proteolysis of FLG proceeds in the outer
part of the SC (Scott and Harding, 1986). To investigate
whether the timing of these events is affected in caspase-14-
deficient mice, we analyzed skin lysates of caspase-14þ /þ
and caspase-14/ mice at different developmental stages,
ranging from E15.5 until P5.5 (Figure 2). FLG repeat
formation, which coincides with SC formation and caspase-
14 activation, was detectable from day E17.5 in caspase-14þ /
þ and caspase-14/ mice, confirming previous reports
(Fischer et al., 2005). Our results indicate that FLG
degradation is initiated from day E18.5 in both wild-type
and caspase-14/ mice. In wild-type mice, FLG degradation
products were observed from day E18.5 to P0.5. From day
P1.5 these fragments were hardly detectable in complete skin
lysates from caspase-14þ /þ mice, indicating that they are
rapidly degraded after birth. In contrast, FLG fragments of
17–30 kDa tended to accumulate in caspase-14-deficient skin
from day P0.5. These data indicate that caspase-14 is crucial
for FLG degradation in the SC.
Caspase-14 can directly cleave the FLG repeat
Our biochemical analysis of skin lysates indicates that the
FLG repeat needs to be cleaved by caspase-14 before it can
be further degraded into amino acids (Figure 1). We
previously reported that caspase-14 can directly cleave an
N-terminal profilaggrin fragment spanning the A and B
domains and a partial FLG repeat (Denecker et al., 2007).
To determine whether human caspase-14 can directly cleave
the FLG repeat, we used recombinant human caspase-14
activated by incubation with an epidermal extract (because
caspase-14 does not auto-activate by overexpression) to
cleave a human FLG repeat (FLAG-FG) that was translated
in vitro and labeled with [35S]methionine (Dale et al., 1997).
The protein representing the FLG repeat was clearly degraded
by caspase-14 (Figure 3a). However, no cleavage products
were apparent on the autoradiogram, most likely because
only one methionine residue (initiation AUG) is present in the
radioactively labeled FLG repeat, which might be present in a
small cleavage product that cannot be detected using 15%
SDS–PAGE. Treatment of the FLG repeat with active caspase-
14 in the presence of the pan-caspase inhibitor zVAD-fmk,
or with a catalytic inactive mutant of caspase-14, did not
result in FLG processing (Supplementary Figure S2 online). In
addition, depletion of active caspase-14 from the incubation
mixture abolished FLG repeat cleavage (Figure 3a). To
identify the caspase-14 cleavage sites, we made use of a
recombinant human FLG repeat, as used previously in other
studies (Kamata et al., 2009). To avoid generating active
caspase-14 by treatment of procaspase-14 with an undefined
epidermal extract, we expressed the human caspase-14 p20
and p10 subunits separately in E. coli. During purification,
these subunits were mixed to obtain enzymatically active
p20/p10 caspase-14 heterodimers that mimic in vivo-acti-
vated caspase-14 (Fischer et al., 2004). This was verified by
comparing the substrate specificity of p20/p10 caspase-14 to
that of cleaved caspase-14 (Supplementary Figure S3 online).
When the FLG repeat unit was incubated with the hetero-
dimers, several FLG cleavage fragments were generated
(Figure 3b). We analyzed these fragments by mass spectro-
metry and identified two caspase-14 cleavage sites (Figure 3c
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Figure 2. Accumulation of filaggrin-derived peptides in caspase-14/ skin increases after birth. (a, b) Western blot analysis of filaggrin (FLG, a) and
caspase-14 (b) was performed on total skin lysates from caspase-14þ /þ and caspase-14/ mice. Skin lysates were prepared from mice on embryonic days
E15.5, E16.5, E17.5, and E18.5 and the first neonatal days (P0.5–P5.5). Complete skin was lysed in urea-Tris buffer. Positions of FLG repeat, procaspase-14, and
the large (p20) and small (p10) catalytic subunits are indicated by arrows. Mw, molecular weight markers.
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and d), namely, VSQD and HSED. These sites are situated
near the middle of the FLG repeat and are conserved in most
of the FLG repeats (Figure 3e). The FLG cleavage pattern
indicates the presence of other caspase-14 cleavage sites, but
the peptides corresponding to these cleavage sites might be
difficult to detect. Taken together, our data show that the FLG
repeat is a direct substrate of caspase-14.
NMF levels are strongly reduced in SC of caspase-14/ mice
NMF components derived from amino acids originate mainly
from complete degradation of FLG (Scott et al., 1982).
Because FLG degradation is defective in caspase-14-deficient
epidermis, we used these mice to investigate the physiolo-
gical role of caspase-14 in the formation of NMF. We
analyzed the relative NMF levels of caspase-14þ /þ and
caspase-14/ back skin by means of in situ Raman spectro-
scopy (Caspers et al., 2001). The relative NMF levels in
caspase-14/ skin were three times lower than in caspase-
14þ /þ skin (Figure 4a). In keeping with the reduction in
overall NMF level in caspase-14/ skin, the levels of two
NMF constituents, trans-urocanic acid (tUCA) and 2-pyrroli-
done-5-carboxylic acid (PCA), were about 2-fold reduced
in caspase-14/ mice (Figure 4a). We wanted to exclude
the possibility that decreased UCA and PCA levels are caused
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Figure 3. Direct cleavage of the human filaggrin repeat by caspase-14. (a) The construct harboring complementary DNA of a human filaggrin (FLG) repeat
was transcribed and translated in vitro in the presence of 35S-methionine. Translated products were left untreated or incubated with the indicated
concentrations of recombinant active cleaved human caspase-14 in buffer containing 1.1 M kosmotropic salt. As a control, 20mM of the pan-caspase inhibitor
zVADfmk was added or caspase-14 was depleted from the reaction. (b) Recombinantly expressed human FLG repeat (Kanno et al., 2000) was incubated
with a 20:1 ratio of p20/p10 caspase-14 for 1 hour in the absence or presence of 20mM zVADfmk. Numbered protein bands were cut out of the gel and
analyzed by means of mass spectrometry to identify caspase cleavage sites. (c) Peptides identified during the mass spectrometry analysis that were generated
as a result from cleavage by caspase-14 after an aspartate residue. These peptides were not identified in the non-cleaved FLG repeat band. We identified
the HSED cleavage site also in cleaved protein band 1 (panel b), which is not in agreement with the apparent molecular weight of this band. Therefore we
believe this is due to a minor contamination of band 1 with other cleaved FLG fragments, which can be detected by an ultrasensitive method such as mass
spectrometry. (d) Amino-acid sequence of the recombinantly expressed human FLG repeat, with indication of the identified caspase-14 cleavage sites
(underlined). The sequence of the partial linker sequence present in the construct is indicated in bold italics. C-terminal His-tag is indicated in bold.
(e) Schematic representation of human profilaggrin with indication of VSQD and HSED positions throughout the molecule. In repeat 3 and in the
C-terminal partial repeat the HSED site was replaced by HSDD or YPED, respectively. In repeat 7 the VSQD site was replaced by FSQD.
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by inhibition of the conversion of histidine to UCA or
glutamine to PCA, respectively. As the mouse FLG unit is
composed of 15% glycine (Supplementary Figure S1 online),
we analyzed the level of this amino acid in caspase-14þ /þ
and caspase-14/ skin. As expected, glycine levels were
drastically reduced in caspase-14/ mice (Figure 4a),
indicating that caspase-14 acts at the level of FLG degrada-
tion and not at the level of amino-acid conversion.
We also determined the amount of PCA and total UCA
(trans and cis form) in caspase-14þ /þ and caspase-14/ SC
by biochemically analyzing samples obtained from skin tape
stripping experiments. The concentrations of PCA and UCA
were normalized for the amount of total protein present in the
tape strip samples. Consistent with the results obtained by
Raman spectroscopy, this analysis indicated that the levels of
both NMF constituents were significantly lower in caspase-
14-deficient samples (Figure 4b).
DISCUSSION
The adaptation of vertebrates to terrestrial life was accom-
panied by drastic changes in the integument to cope with the
dry environment and protect against excessive water loss
(Alibardi, 2003). The generation of a soft SC in mammals
correlates with the occurrence of histidine-rich proteins such
as profilaggrin. Patients or mice carrying FLG loss-of-function
mutations suffer from dry and/or scaly skin (Presland et al.,
2000; Nemoto-Hasebe et al., 2009). However, the pathways
involved in FLG degradation to NMF are poorly characterized.
We show that caspase-14 can directly cleave the FLG
repeat, probably in preparation for complete breakdown by
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Figure 4. NMF levels are significantly reduced in caspase-14-deficient mice. (a) Raman spectroscopic determination of the relative levels of natural
moisturizing factor (NMF), pyrrolidone carboxylic acid (PCA), trans-urocanic acid (tUCA), and glycine in caspase-14þ /þ (n¼8) and caspase-14/ (n¼ 6) mice
on day P5.5. All mice were measured at 10 different locations. For both genotypes the mean values of the measurements between 0 and 10 mm below
the skin surface were calculated per mouse, and compared by the Mann–Whitney U-test. (b) Biochemical determination of the average PCA and tUCA
concentrations in caspase-14þ /þ (n¼6) and caspase-14/ mice (n¼ 6). TS1 (tape strip 1) represents the upper layer of the stratum corneum (SC), and TS10 is
derived from the deeper layers of the SC. Concentrations of PCA and tUCA were normalized for the amount of protein determined on the tape strips and
expressed as nmol g1 protein. Error bars represent the standard deviation. All values from the two genotypes were compared using Mann–Whitney U-testing;
NS, not significant; UCA, urocanic acid; P-values are indicated with * (o0.05), ** (0.05–0.001), or *** (o0.001).
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other, currently unidentified, proteases. The latter is sup-
ported by the finding that lysates from caspase-14/
epidermis accumulate FLG fragments. In addition, immuno-
histochemical staining detects FLG only in the deeper layers
of the wild-type SC, while FLG is present in all layers of the
SC in caspase-14-deficient mice (Denecker et al., 2007,
2008). We identified two caspase-14 cleavage sites in the
human FLG repeat: VSQD and HSED. The cleavage pattern
suggests the presence of additional caspase-14 cleavage sites,
but we could not identify them. The presence of valine and
histidine at position P4 in the cleavage sites that we identified
is in agreement with the observed preference of caspase-14
for hydrophobic or aromatic residues at P4 (Mikolajczyk
et al., 2004). These two caspase-14 cleavage sites were
conserved in most of the human FLG repeats (Figure 3e). An
additional HSED site was present in the C terminus of several
repeats. These caspase-14 cleavage sites are not conserved in
mouse FLG. However, several putative caspase-14 cleavage
sites can be predicted in mouse filaggrin by using Sitepredic-
tion software (Verspurten et al., 2009).
In vivo Raman spectroscopy and biochemical analysis
revealed that the total NMF levels and tUCA and PCA levels
were B2.5 times lower in caspase-14/ mice compared
with wild-type mice, confirming the important role of
caspase-14 in FLG degradation. This could explain the lower
SC hydration levels in caspase-14/ mice (Denecker et al.,
2007). tUCA represents B0.7% of the dry weight of the
human skin and serves as an efficient UVB-absorbing
chromophore and is thereby converted to cis-UCA, which
has immunosuppressive activities (de fine Olivarius et al.,
1996; Walterscheid et al., 2006). In view of this, one might
expect that humans and mice deficient in FLG, caspase-14,
or histidase are more prone to UVB-induced DNA damage
and inflammatory stimuli. Indeed, caspase-14/ and
histidase/ mice (Denecker et al., 2007; Barresi et al.,
2011), and in vitro human skin equivalents, in which FLG
expression was suppressed (Mildner et al., 2010), are more
susceptible to UVB-induced DNA damage and subsequent
apoptosis. Ft/ft mice, which do not have functional FLG,
develop spontaneous skin inflammation and are more
sensitive to cutaneous allergen priming (Fallon et al., 2009;
Oyoshi et al., 2009; Scharschmidt et al., 2009). Whether this
phenotype is caused by the absence of the FLG repeat or by
lack of FLG-derived metabolites is not clear. A putative
mechanism for impairment of epidermal barrier function in ft/
ft mice is the abnormal lamellar body secretion and aberrant
cornified envelope morphology observed in the skin of these
mice (Scharschmidt et al., 2009). Interestingly, mice deficient
in the FLG degrading enzyme bleomycin hydrolase display a
mild ichthyotic-like appearance with generalized scaling
(Schwartz et al., 1999; Kamata et al., 2009). The ‘‘sponta-
neous’’ skin phenotype observed in ft/ft mice and bleomycin
hydrolase-deficient mice is more severe than that seen in
caspase-14/ mice. Apparently, homeostatic formation of
FLG repeats is crucial for skin barrier function, whereas
defects in degradation of FLG lead to milder phenotypes,
such as increased transepidermal water loss, lower levels of
NMFs, or mild scaling. In keeping with the above hypothesis,
decreased NMF levels in nonlesional skin are a recurring
feature in atopic dermatitis (Kezic et al., 2011). This could be
explained by FLG deficiency or lower levels of active
caspase-14 in such patients (Yamamoto et al., 2011).
However, we cannot exclude that other defects, such as
changes in pH or lipid structure, may also contribute to the
caspase-14/ phenotype.
The decreased water content in the upper epidermal
layers, which is caused by the low humidity of the terrestrial
environment, is required for induction of FLG degradation
(Warner et al., 1988; Caspers et al., 2001). Consequently,
experiments using in vitro skin equivalents indicated that
PCA levels are dependent on the environment’s relative
humidity (Bouwstra et al., 2008). This is in accordance with
the reduced level of NMF in humans who live in areas with
high relative humidity (Declercq et al., 2002). The require-
ment for high concentrations of kosmotropic salt to enhance
caspase-14 activity in vitro might mimic the low hydration
status of the top layers of the SC (Mikolajczyk et al., 2004).
Kosmotropic salts induce both dimerization and ordering of
active site loops by partial desolvation of the protein.
It should be noted that residual NMF, tUCA, and PCA
levels were detected in caspase-14-deficient skin. This could
imply that a pool of FLG repeats was still being broken down
or that FLG was not the only source of amino acids
contributing to NMF synthesis. The latter is consistent with
the presence of some NMF in SC of patients who carry
homozygous loss-of-function FLG mutations (Kezic et al.,
2008, 2009; O’Regan et al., 2010). It also confirms
quantitative studies showing that between 70 and 100% of
the total SC free amino acids are derived from FLG (Scott
et al., 1982). It is tempting to consider the other members of
the S100-fused gene family as the main contributors of these
residual NMF. It would be interesting to analyze NMF levels
in mice that lack multiple fused S100 proteins, especially the
two more closely related members hornerin and ifapsoriasin
(also referred to as FLG-2). Further research is needed to
determine the in vivo role of these fused S100 family
members.
To conclude, we provide in vivo and in vitro evidence that
identifies caspase-14 as a crucial protease in the generation
of NMF (Figure 5). FLG repeat degradation is initiated in the
deeper cornified layers, eventually leading to the generation
of free amino acids, the main source of NMF (Scott and
Harding, 1986; Jokura et al., 1995). In caspase-14/ mice,
FLG peptides accumulate in these layers and NMF formation
is defective. These findings indicate that caspase-14 is a
crucial protease in FLG catabolism.
MATERIALS AND METHODS
Animals
Caspase-14 knockout mice were generated as described (Denecker
et al., 2007). Skin was prepared from embryos at E15.5, E16.5, E17.5,
and E18.5, and on postpartum days P0.5, P1.5, P2.5, P3.5, P4.5, and
P5.5. We also used adult female mice at the age of 8–12 weeks.
The animals were housed under specific pathogen free conditions,
and all experiments were approved by the local ethics committee of
Ghent University.
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Immunoblotting
Mice were killed and full skin or epidermal samples were obtained
and frozen in NP-40 buffer (10mM Tris-HCl, pH 7.4, 10mM NaCl,
3mM MgCl2 and 1% (w/v) NP-40) and freeze-thawed 10 times in
liquid nitrogen. Skin samples from timed mating experiments were
frozen in urea-Tris buffer (8 M urea, 10mM EDTA, 50mM Tris-HCl,
pH 8, 0.3mM orthophenanthroline and 20 mgml1 phenylmethyl-
sulfonyl fluoride) and homogenized by sonication. Homogenates
were centrifuged at 0 1C for 30minutes at 14,000 g. Epidermal
lysates were obtained by separating the epidermis from dermis after
incubating the skin for 10minutes at 56 1C in phosphate-buffered
saline with 10mM EDTA. We separated 20 mg of protein in 15%
SDS–PAGE and transferred them to a nitrocellulose membrane. The
membrane was incubated with primary antibodies and appropriate
horseradish peroxidase-labeled secondary antibodies (GE Health-
care, Diegem, Belgium). The primary antibodies were 1:2,000 rabbit
polyclonal caspase-14 (Lippens et al., 2000), 1:1,000 rabbit
polyclonal anti-FLG (Covance, Princeton, NJ), and 1:20,000 mouse
monoclonal anti-actin (MP Biomedicals, Illkirch, France). Detection
was performed with the Western Lightning chemiluminescent
reagent plus kit (PerkinElmer, Waltham, MA).
Caspase-14 cleavage assay
The sequence of a human FLG repeat flanked by an N-terminal Flag-
tag was cloned in the pcDNA3 vector (Dale et al., 1997). Using this
vector [35S]Methionine-labeled human FLG protein was prepared
with the coupled transcription-translation assay TNT kit (Promega,
Leiden, The Netherlands). Recombinant bacterially expressed
human FLG repeat was produced and purified according to the
method reported by Kanno et al. (2000). Recombinant, processed,
enzymatically active human caspase-14 (C14 WT) was obtained by
incubating purified human recombinant procaspase-14 either with
an epidermal extract containing a caspase-14-activating enzyme
(i.e., cleaved caspase-14, see Supplementary Material and Methods
online) or with enzymatically active p20/p10 human caspase-14
(p20/p10 caspase-14) produced by expressing the p20 and p10
subunits from the pLT32 bacterial expression vector (Mertens et al.,
1995). The p20 and p10 subunits were purified from inclusion
bodies by denaturation–renaturation and Q-source chromatography.
To check whether they have the same substrate specificity as the
native recombinant human caspase-14 obtained by cleavage of
procaspase-14 between the p20 and p10 subunits, we compared
their activities on fluorescent caspase substrates (Supplementary
Figure S3 online). The enzymatic activity profiles of these two
preparations of active human caspase-14 were identical to those
described by others (Fischer et al., 2004; Mikolajczyk et al., 2004).
Radioactive-labeled FLG repeat translation products were incubated
with caspase-14 for 3 hours at 37 1C as described (Mikolajczyk et al.,
2004). We added 1mM of the pan-caspase inhibitor zVAD-fmk
(Bachem, Bubendorf, Switzerland) to inactivate caspase-14, or
else we used a recombinant, processed, catalytic inactive human
caspase-14 mutant (C14 C/A), which has a cysteine to alanine
mutation at the catalytic site C132. Depletion of His-tagged
recombinant caspase-14 was achieved by incubation with Ni2þ
Sepharose beads (Amersham Biosciences, Diegem, Belgium) for
2 hours at 4 1C on a rotating platform. Reaction samples, containing
4ml of translation mix (6 microCurie), were precipitated with
trichloroacetic acid overnight at 20 1C. After centrifugation, pellets
were washed twice with acetone and dissolved in loading buffer.
Proteins were separated by 15% SDS–PAGE. Gels were incubated for
30minutes in fixation buffer (10% acetic acid, 25% isopropanol and
0.5% (w/v) L-methionine) and afterwards incubated in amplifier
solution (Amersham Amplify Fluorographic Reagent, Amersham
Biosciences). Gels were vacuum-dried and cleavage events
were examined after autoradiography. Bacterially expressed FLG
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Figure 5. Hypothetical overview of the pathway involved in filaggrin
degradation. Insoluble profilaggrin is stored in the stratum granulosum (SG) in
keratohyalin granules. Upon dephosphorylation, profilaggrin is released in the
cytosol, where it is proteolysed into filaggrin (FLG) repeats. FLG binds and
strengthens keratin intermediate filaments (KIFs), thereby promoting cell
flattening at the SG-SC transitional layer. Deimination of FLG within the SC,
probably by PAD 1 and PAD 3, has been suggested to render FLG susceptible
to further proteolysis. FLG repeats also become crosslinked by
transglutaminases to strengthen the cornified envelopes. FLG degradation
starts in the deeper SC layers by partial proteolysis by one or more unknown
proteases. Next, caspase-14-mediated cleavage prepares these fragments for
efficient degradation into free amino acids, which contribute to the natural
moisturizing factors (NMFs). Calpain 1 and bleomycin hydrolase also
participate in this process. However, the order of events is not clear. NMFs
provide SC hydration and possibly also UVB protection and immune
suppression. PAD, peptidylarginine deiminase.
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monomer was incubated with p20/p10 caspase-14 (20:1 ratio) for
1 hour at 37 1C in the presence or absence of 1mM zVAD-fmk.
Samples were analyzed using SDS–PAGE and Coomassie Blue
staining.
Protein identification by liquid chromatography–mass
spectrometry/mass spectrometry analysis
Proteins were in-gel digested overnight at 37 1C with 0.1mg of
sequencing-grade-modified trypsin (Promega, Madison, WI). The
resulting peptide mixture was applied for nano-liquid chromatogra-
phy–mass spectrometry/mass spectrometry analysis on an Ultimate
(Dionex, Amsterdam, The Netherlands) in-line connected to an
Esquire HCT mass spectrometer (Bruker, Bremen, Germany). The
fragmentation spectra were converted to Mascot generic files (mgf
files) using the Automation Engine software (version 3.2, Bruker) and
were searched using the MASCOT database search engine against the
IPI database (taxonomy Mus Musculus) extracted from the EBI
website (v3.16—http://www.ebi.ac.uk/IPI). MASCOT’s parameter
settings were as follows: enzyme: trypsin/P and variable modifica-
tions: acetyl (N-term), propionamide (C), oxidation(M), pyro-glu
(N-term Q), peptide mass and fragment mass tolerances: ±0.5 kDa,
maximum number of missed cleavages: 1 and instrument type: ESI-
TRAP. Only spectra exceeding Mascot’s identity threshold score (set
at the 95% confidence level) and that were ranked first were retained.
Raman spectroscopy
Raman measurements were performed using model 3510
Skin Composition Analyzer (River Diagnostics, Rotterdam, The
Netherlands). The instrument is optimized for rapid in vivo
measurements on the skin and offers an axial spatial resolution of
o5mm. It comprises a dispersive spectrometer and a continuous-
wave solid-state laser with an emission wavelength of 785 nm.
Raman spectra are recorded in the 400–1800 cm1 spectral range
with a spectral resolution of 5 cm1. The spectrometer is connected
to a confocal measurement stage, which is essentially an inverted
microscope. The skin is placed on a fused silica window in the
measurement stage. Focusing at different depths in the skin at 0.1 mm
resolution is controlled by the instrument and the axial displace-
ments are stored with the collected Raman spectra. For lateral
positioning, the fused silica window can be moved in one dimension
in steps of 50mm. A built-in video camera enables visual inspection
of the skin surface to avoid wrinkles and hairs during data collection.
For ex vivo Raman measurements of NMF concentration profiles, a
piece of 1 1 cm2 full-thickness skin from the back of newborn
(P5.5) caspase-14 wild-type and knockout mice was placed on the
measurement stage. The Raman spectra were recorded from the skin
surface down to a depth of 30 mm in 2-mm steps. In this way, detailed
Raman profiles were acquired across the SC and the upper part of the
viable epidermis. Because of the heterogeneity of the skin at the
microscopic scale, all measurements were repeated 10 times at
different locations that were 0.1–5mm apart. Raman spectra were
recorded from eight caspase-14þ /þ mice and six caspase-14/
mice. For each mouse, we calculated the average NMF, PCA, and
tUCA content of measurements between 0 and 10 mm from the skin
surface. Both groups were compared by the Mann–Whitney U-test. A
P-value of 0.05 was used as a cut-off for statistical significance. All
tests were two-sided; analyses were performed using SPSS 15.0
(SPSS, IBM, Chicago, IL).
Sequential SC tape stripping and measurement of UCA and PCA
by high-pressure liquid chromatography
The levels of PCA and tUCA on lysates from tape-strips obtained
from caspase-14þ /þ and caspase-14/ mice were determined by
using a method based on high-pressure liquid chromatography
quantification (Kezic et al., 2009, 2011). For technical details see
Supplementary Material and Methods online section. Data from the
groups were compared by Mann–Whitney U-testing.
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